شنبه 23 آبان 1405
[Archive]
دوره 24، شماره 9 - ( 6-1405 )
جلد 24 شماره 9 صفحات 860-859 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nasirian M. Can injectable glucose-lowering agents affect erectile function in men? A letter to the editor. , Int J Reprod BioMed.. 2026; 24 (9) :859-860
URL: http://ijrm.ir/article-1-3956-fa.html
URL: http://ijrm.ir/article-1-3956-fa.html
Can injectable glucose-lowering agents affect erectile function in men? A letter to the editor. ، International Journal of Reproductive BioMedicine. 1405; 24 (9) :859-860
چکیده: (140 مشاهده)
این مقاله فاقد چکیده میباشد.
نوع مطالعه: Letter to Editor |
فهرست منابع
1. Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The quality of life and economic burden of erectile dysfunction. Res Rep Urol 2021; 13: 79-86. [DOI:10.2147/RRU.S283097] [PMID] [PMCID]
2. Terentes-Printzios D, Ioakeimidis N, Rokkas K, Vlachopoulos C. Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs. Nat Rev Cardiol 2022; 19: 59-74. [DOI:10.1038/s41569-021-00593-6] [PMID]
3. Allen MS, Wood AM, Sheffield D. The psychology of erectile dysfunction. Curr Dir Psychol Sci 2023; 32: 487-493. [DOI:10.1177/09637214231192269]
4. Bajaj HS, Gerstein HC, Rao-Melacini P, Basile J, Colhoun H, Conget I, et al. Erectile function in men with type 2 diabetes treated with dulaglutide: An exploratory analysis of the REWIND placebo-controlled randomised trial. Lancet Diabetes Endocrinol 2021; 9: 484-490. [DOI:10.1016/S2213-8587(21)00115-7] [PMID]
5. Lisco G, Bartolomeo N, De Tullio A, De Pergola G, Guastamacchia E, Jirillo E, et al. Long-acting glucagon-like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction: A retrospective cohort study. Andrology 2024; 12: 633-642. [DOI:10.1111/andr.13519] [PMID]
6. Able C, Liao B, Saffati G, Maremanda A, Applewhite J, Nasrallah AA, et al. Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: A TriNetX database study. Int J Impot Res 2025; 37: 315-319. [DOI:10.1038/s41443-024-00895-6] [PMID]
7. Pourabhari Langroudi A, Chen AL, Basran S, Sommer ER, Stinson J, Cheng Y-S, et al. Male sexual dysfunction associated with GLP-1 receptor agonists: A cross-sectional analysis of FAERS data. Int J Impot Res 2025; 37: 661-667.
https://doi.org/10.1038/s41443-025-01061-2 [DOI:10.1038/s41443-025-01143-1] [PMID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
